(Q33632278)

English

Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

12

object named as

Agnès Buzyn

0 references

object named as

Norbert Ifrah

18

0 references

19

object named as

Hervé Dombret

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Sébastien Maury

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Françoise Huguet

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Thibaut Leguay

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Francis Lacombe

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Marc Maynadié

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sandrine Girard

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Adrienne de Labarthe

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Emilienne Kuhlein

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Emmanuel Raffoux

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Xavier Thomas

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Patrice Chevallier

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

André Delannoy

13

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yves Chalandon

14

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jean-Paul Vernant

15

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Philippe Rousselot

16

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Elizabeth Macintyre

17

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Marie-Christine Béné

20

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Group for Research on Adult Acute Lymphoblastic Leukemia

21

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

22 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

324-328

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

21 June 2018

Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

21 June 2018

Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

21 June 2018

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

21 June 2018

Treatment of acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

21 June 2018

Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

21 June 2018

Antibody-based therapy of human leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

21 June 2018

Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

21 June 2018

Multinomial regression models based on continuation ratios

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

21 June 2018

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

30 October 2018

Treatment of adult acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

30 October 2018

High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

30 October 2018

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

30 October 2018

Optic nerve relapse in a child with common acute lymphoblastic leukemia, treated with systemic anti-CD-20 (rituximab).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

30 October 2018

Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

30 October 2018

Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817037

30 October 2018

Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19773266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19773266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/19773266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19773266

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2009.010306

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33632278&oldid=1586494624"